Hameem Ibne Kawsar, a Bangladeshi-American physician, has been appointed as the director of Internal Medicine Residency Programme at a hospital in Maryland, USA. He will assume new responsibilities from July this year.
Dr Hameem Ibne Kawsar discovered methods for early detection of oral cancer which introduced him to the American scientific community. Then he completed a residency in internal medicine from the world-renowned Cleveland Clinic Hospital.
Dr Hameem received the 'Best Research' medal for his meritorious contribution. After being Board Certified in Internal Medicine in the United States, he successfully served as Associate Program Director of the Internal Medicine Residency Program at St Luke's Hospital in St. Louis, Missouri. At the same time he also served as the Medical Director of the Residents Continuity Clinic. He was also appointed as the Director of Research and Scholarly Activities at the same hospital. During this time, under his supervision, American residents completed about 15 studies and won national awards in the United States.
Cancer scientist Dr Hameem was awarded the 'Teacher of the Year' medal for his outstanding performance. Dr Hameem has also successfully served as a judge at scientific sessions of various national organisations of American physicians. He is currently completing a three-year clinical fellowship in hematology and oncology from the University of Kansas Medical Centre in the United States.
He recently published a ground-breaking research paper on the treatment of lung cancer and its failure in a scientific journal. In addition to training residents, he will be engaged in cancer research and cancer research in collaboration with world-renowned Johns Hopkins University. He is currently living in Missouri, USA, with his wife and two daughters.
Dr Hameem was born in Bagerhat. He completed his HSC from Notre Dame College. Then he enrolled in the MBBS course at Barisal Sher-e-Bangla Medical College. He received the certificate of health service in 1997. Dr Hameem completed his doctorate degree in molecular biology in 2005. Later he continued his studies and become a cancer biologist at Cleveland's Western Reserve University.